Doripenem

Doripenem is an antibacterial drug formulated for intravenous administration. It has a broad spectrum of activity against gram-positive and gram-negative bacteria, including many strains resistant to other antibiotics.

It binds to penicillin-binding proteins (PBPs), which prevents bacterial cell wall synthesis. It belongs to a class of drugs called Carbapenems. Doripenem does not work for viral infections such as flu.

It can help to reduce the number of bacteria. It can help to fight against the infection caused by the bacteria. The bactericidal activity of the drug was found to be due to inhibition of essential bacterial enzyme - peptidoglycan synthesis.

Doripenem is a useful antibiotic in the treatment of infections caused by various bacteria. The drug is useful in treating pneumonia, lung and skin infections, gastrointestinal tract infections, infections in ears and sinuses, 等.

It can treat bacteria like Acinetobacter baumanni, Pseudomonas aeruginosa, Enterobacter cloacae, and Klebsiella pneumoniae. Doripenem can help to reduce the number of bacteria.

It can help to fight against the infection caused by the bacteria. The drug is also useful in the treatment of multi-drug resistant TB (MDR-TB).

It is used to treat complicated skin infections, pneumonia, urinary tract infection, acute bacterial skin infections, and severe intestinal infection. It is also used for the treatment of infections caused by susceptible organisms.